Identification of transforming growth factor beta1-driven genetic programs of acute lung fibrosis.
暂无分享,去创建一个
I. Wang | Y. Boie | J. Menetski | J. Mortimer | A. Pulichino | Lijing Xu | C. E. Sayegh | J. Elias | A. Caron | A. Auger | A. Kartono | C. Sayegh | Anick Auger | Anne-Marie Pulichino
[1] R. Homer,et al. Transforming Growth Factor (TGF)-β1 Stimulates Pulmonary Fibrosis and Inflammation via a Bax-dependent, Bid-activated Pathway That Involves Matrix Metalloproteinase-12* , 2007, Journal of Biological Chemistry.
[2] T. Wynn,et al. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.
[3] K. Matsushima,et al. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. , 2007, The American journal of pathology.
[4] E. Mazzon,et al. Genetic and pharmacological inhibition of GITR‐GITRL interaction reduces chronic lung injury induced by bleomycin instillation , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] Xia Zhang,et al. Biochemical and functional characterization of three activated macrophage populations , 2006, Journal of leukocyte biology.
[6] W. Berger,et al. The activin axis in liver biology and disease. , 2006, Mutation research.
[7] E. Turley,et al. Osteopontin Induction of Hyaluronan Synthase 2 Expression Promotes Breast Cancer Malignancy* , 2006, Journal of Biological Chemistry.
[8] S. Rennard,et al. Transforming Growth Factor-β Receptor Type 1 (TGFβRI) Kinase Activity but Not p38 Activation Is Required for TGFβRI-Induced Myofibroblast Differentiation and Profibrotic Gene Expression , 2006, Molecular Pharmacology.
[9] P. Noble,et al. Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity. , 2006, Proceedings of the American Thoracic Society.
[10] R. Homer,et al. Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. , 2006, Proceedings of the American Thoracic Society.
[11] M. Selman,et al. Matrix metalloproteases in aberrant fibrotic tissue remodeling. , 2006, Proceedings of the American Thoracic Society.
[12] M. Rojas,et al. Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. , 2006, American journal of respiratory cell and molecular biology.
[13] Antje Prasse,et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. , 2006, American journal of respiratory and critical care medicine.
[14] R. Bucala,et al. The role of circulating fibrocytes in fibrosis , 2006, Current rheumatology reports.
[15] Richard A Flavell,et al. Transforming growth factor-beta regulation of immune responses. , 2006, Annual review of immunology.
[16] L. Murray,et al. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. , 2006, American journal of respiratory cell and molecular biology.
[17] G. Frantz,et al. Cutting Edge: Novel Human Dendritic Cell- and Monocyte-Attracting Chemokine-Like Protein Identified by Fold Recognition Methods , 2006, The Journal of Immunology.
[18] Naftali Kaminski,et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. , 2006, American journal of respiratory and critical care medicine.
[19] F. Ricciardolo,et al. The therapeutic potential of drugs targeting the arginase pathway in asthma , 2005, Expert opinion on investigational drugs.
[20] Naftali Kaminski,et al. Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis , 2005, PLoS medicine.
[21] M. Hallett,et al. Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions , 2005, Journal of Medical Genetics.
[22] R. Lafyatis,et al. Increased expression of type I collagen induced by microfibril-associated glycoprotein 2: novel mechanistic insights into the molecular basis of dermal fibrosis in scleroderma. , 2005, Arthritis and rheumatism.
[23] C. Donner,et al. CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis , 2005, European Respiratory Journal.
[24] Guanghui Hu,et al. Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts. , 2005, The Journal of allergy and clinical immunology.
[25] S. Forbes,et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.
[26] J. Milbrandt,et al. Early Growth Response Gene 1–mediated Apoptosis Is Essential for Transforming Growth Factor β1–induced Pulmonary Fibrosis , 2004, The Journal of experimental medicine.
[27] P. Anderson,et al. Post‐transcriptional regulation of proinflammatory proteins , 2004 .
[28] E. Devilard,et al. DNAM-1 and PVR Regulate Monocyte Migration through Endothelial Junctions , 2004, The Journal of experimental medicine.
[29] A. Takeshita,et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[30] M. Wynes,et al. Induction of Macrophage Insulin-Like Growth Factor-I Expression by the Th2 Cytokines IL-4 and IL-131 , 2003, The Journal of Immunology.
[31] V. Tkach,et al. Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility , 2003, Oncogene.
[32] B. Winston,et al. Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease. , 2002, Chest.
[33] P. De Baetselier,et al. FIZZ1 and Ym as Tools to Discriminate between Differentially Activated Macrophages , 2002, Developmental immunology.
[34] R. Stockley,et al. A randomized, placebo-controlled trial of a leukotriene synthesis inhibitor in patients with COPD. , 2002, Chest.
[35] Naftali Kaminski,et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[36] Takahiro Sawai,et al. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Homer,et al. Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.
[38] Naftali Kaminski,et al. TGF-β is a critical mediator of acute lung injury , 2001 .
[39] C. Lisboa,et al. Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis. , 2001, American journal of respiratory and critical care medicine.
[40] R. Flavell,et al. Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. , 2000, American journal of respiratory cell and molecular biology.
[41] David G. Morris,et al. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[42] Francisco Portillo,et al. The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.
[43] S. Uh,et al. Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.
[44] K. Csaky,et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. , 1997, The Journal of clinical investigation.
[45] T. Dipetrillo,et al. Collagen lysyl oxidase activity in the lung increases during bleomycin-induced lung fibrosis. , 1981, The Journal of pharmacology and experimental therapeutics.
[46] R. Strieter,et al. Mechanisms and mediators of pulmonary fibrosis. , 2005, Critical reviews in immunology.
[47] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.